Acceptability of home use of mifepristone for medical abortion-Reference-Cited by-同舟云学术

Acceptability of home use of mifepristone for medical abortion

Published:2013-07 Issue:1 Volume:88 Page:122-127
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Swica Yael,Chong Erica,Middleton Tamer,Prine Linda,Gold Marji,Schreiber Courtney A.,Winikoff Beverly

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference23 articles.

1. Danco Laboratories. Mifeprex prescribing information. Rev 4:4/22/09, accessed at http://www.earlyoptionpill.com/userfiles/file/Mifeprex%20Labeling%204–22–09_Final_doc.pdf.

2. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services;Gomperts;BJOG,2008

3. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone;Akin;Eur J Contracept Reprod Health Care,2009

4. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone;Arvidsson;Eur J Obstet Gynecol Reprod Biol,2005

5. Experience and acceptability of medical abortion with mifepristone and misoprostol among U.S. women;Beckman;Wom Health Iss,1997

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brief of over 300 reproductive health researchers as Amici Curiae in FDA v. Alliance for Hippocratic Medicine;Perspectives on Sexual and Reproductive Health;2024-07-29

2. Impact of approval of home use of misoprostol in England on access to medical abortion: An interrupted time series analysis;International Journal of Gynecology & Obstetrics;2023-08-24

3. Understanding Women's Communication with Their Providers During Medication Abortion and Abortion Pill Reversal: An Exploratory Analysis;The Linacre Quarterly;2023-05

4. Medical methods for first trimester abortion;Cochrane Database of Systematic Reviews;2022-05-24

5. Women’s experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID‐19) pandemic: a qualitative evaluation;BJOG: An International Journal of Obstetrics & Gynaecology;2021-07-27